Literature DB >> 11868127

Sleep-Breathing Disorders and Heart Failure.

Stefan Thalhofer1, Peter Dorow.   

Abstract

Cheyne-Stokes respiration is known to be associated with severe left heart failure. Because of severe desaturation, sleep fragmentation, arousals, and an increase in sympathetic activity, Cheyne-Stokes respiration may lead to a further impairment of cardiac function and to a worsening of quality of life. Although the pathology of Cheyne-Stokes respiration is not fully understood, enhanced chemoreceptor sensitivity, prolonged circulation time, as well as decreased pulmonary gas stores and increased ventilatory drive may be contributing factors. Therapeutic options include the improvement of cardiac failure; medical treatment, such as using theophylline; continous positive airway pressure ventilation; and low-flow oxygen supply. Because of severe cardiac insufficiency, change of endothoracic pressure may worsen the hemodynamic situation in some patients. Therefore, this form of treatment has to be used carefully. Another possible treatment is a low-flow oxygen supply, which will prevent severe desaturations. This therapeutic approach might be a good alternative to noninvasive ventilation. However, it is controversial whether oxygen supply will improve quality of sleep of the patients, even in long-term treatment.

Entities:  

Year:  2000        PMID: 11868127     DOI: 10.1007/s11325-000-0103-0

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  45 in total

1.  Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure.

Authors:  S Javaheri
Journal:  Circulation       Date:  2000-02-01       Impact factor: 29.690

2.  The entrainment of low frequency breathing periodicity.

Authors:  T W Millar; P J Hanly; B Hunt; M Frais; M H Kryger
Journal:  Chest       Date:  1990-11       Impact factor: 9.410

3.  The causes of periodic or Cheyne-Stokes breathing.

Authors:  C G Douglas; J S Haldane
Journal:  J Physiol       Date:  1909-06-15       Impact factor: 5.182

4.  Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities.

Authors:  M J Sullivan; M B Higginbotham; F R Cobb
Journal:  Circulation       Date:  1988-03       Impact factor: 29.690

Review 5.  Pathophysiologic and therapeutic implications of sleep apnea in congestive heart failure.

Authors:  T D Bradley; J S Floras
Journal:  J Card Fail       Date:  1996-09       Impact factor: 5.712

6.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.

Authors:  P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

7.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations.

Authors:  S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

8.  Comparison of aortic and carotid chemoreceptor responses to hypercapnia and hypoxia.

Authors:  S Lahiri; A Mokashi; E Mulligan; T Nishino
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-07

9.  [Oxygen saturation and sleep structure in patients with dilated cardiomyopathy].

Authors:  S Thalhofer; P Dorow; S Schüler; R Hetzer
Journal:  Pneumologie       Date:  1991-05

10.  Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure.

Authors:  N Ambrosino; C Opasich; P Crotti; F Cobelli; L Tavazzi; C Rampulla
Journal:  Eur Respir J       Date:  1994-01       Impact factor: 16.671

View more
  1 in total

1.  Acute pulmonary embolism in patients with obstructive sleep apnoea: does it affect the severity of sleep-disordered breathing?

Authors:  Thomas M Berghaus; Christian Faul; Fabian Unterer; Christian Thilo; Wolfgang von Scheidt; Martin Schwaiblmair
Journal:  Sleep Breath       Date:  2011-12-21       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.